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recIpIents 
In th" paper, "hyp,,"cut, rejection" of 
renal homografts will be discussed on the 
basis of information obtained in hypersen-
sitized dogs. Attention will be focused upon 
three specific topics: ( 1 ) the variety of 
humoral antibodies that may be produced 
in the course of sensitizing a recipient to 
donor tissue; (2) the coagulation changes 
that can be produced within a homograft 
or systemically by transplantation to a pre-
sensitized recipient; (3) the mitigation of 
hyperacute rejection that may be obtained 
by transplantation of consecutive organs 
from the same donor. 
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METHODS 
Pairs of adult mongrel dogs were sensi-
tized to common canine donors by the re-
peated orthotopic transplantation (5 to 8 
times, mean 6) of 2 circular pieces of full-
thickness skin, 3 to 4 cm. in diameter. The 
successive skin grafts were placed within a 
few days after the preceding grafts were re-
jected. The mean times before necrosis was 
evident of the first and last skin transplants, 
respectively, were 8.5 and 2 days. The mean 
time for completion of sensitization was 48 
days. 
Organs were transplanted from the same 
donor an average of 7 days after the last 
exposure to skin, under two general circum-
stances. In control experiments, a donor kid-
ney was inserted by the standard intra-
abdominal technique. In conditioning experi-
ments, the kidney was similarly transplanted 
to specifically sensitized animals but only af-
ter the donor's liver, spleen or other kidney 
was first revascularized in the recipient for 
51 to 240 (mean, 120) minutes. The condi-
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tioning organs were anastomosed to vessels of 
the neck or abdomen. When the liver was 
used, only the hepatic arterial supply was 
restored. 
All but 3 recipients had bilateral nephrec-
tomy. The homograft ureter was drained by 
a cutaneous ureterostomy and urine flow 
was observed 2 or 3 times daily until the de-
velopment of anuria which was taken as the 
time of rejection. All dogs were given 500 to 
1,500 ml. intravenous fluids intraoperatively 
and 500 ml. daily thereafter. 
Systemic blood samples were obtained be-
fore and during sensitization with skin and 
before and after whole organ transplanta-
tion. From these bloods were determined the 
hematocrit, total white blood cell and dif-
ferential counts, and platelet counts.2 Sera 
were analyzed for: (1) isohemagglutinins 
against donor red cells; (2) heterohemag-
glutinins against sheep red cells; (3) anti-
donor leukoagglutinins23 ; (4) antidonor 
lymphocytotoxins determined in the presence 
of pooled male dog complement.21 
In 15 special experiments, arteriovenous 
differences of the aforementioned formed 
blood elements and antibodies were repeti-
tively measured across kidneys, spleens, or 
livers that had been transplanted to pre-
sensitized recipients or alternatively, to nor-
mal dogs. In addition, the following clotting 
tests and assays were performed in citrated, 
platelet-poor plasma: euglobulin lysis timeS; 
thrombin time with 3 units per milliliter 
thrombin; prothrombin time with rabbit 
brain thromboplastin; partial thromboplastin 
time with kaolin15 ; fibrinogen16 ; prothrombin 
(factor II) 13 ; Ac-globulin (factor V) 6; 
antihemophilic globulin (factor VIII) 14 ; 
and plasma thromboplastin component (fac-
tor IX).8 Fibrin split products were quanti-
tatively measured in thrombinized Trasylol 
containing serum according to the meth-
od of Claman and Merrill' except that 
rabbit antidog-fibrinogen antisera were 
employed instead of anti-immunoglobulin 
sera. 
In the experiments for which special path-
ologic studies were planned, fresh tissues 
were fixed with formalin or snap frozen on 
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dry ice. The snap frozen tissue was studied 
for the presence of dog IgG, B1C globulin 
and fibrinogen by a direct immunofluores-
cent method which will be fully described 
elsewhere.26 
RESULTS 
Humoral antibodies with sensitization. Be-
fore skin grafting, 13 of 40 dogs (32.5 per-
cent) had isoagglutinins against donor red 
cells with titers of 1:2 to 1:16 (mean 1:5). 
After sensitization, isoagglutinins became 
detectable (titers 1:2 to 1:64, mean, 1:9) in 
32 dogs (78 percent) (Fig. 1). Another kind 
of hemagglutinin directed against sheep red 
cells was initially present in 39 (97.5 per-
cent) of the animals at titers of 1:2 to 1:16 
(mean, 1:6). The incidence and titers of 
the heterohemagglutinins were not changed 
by the sensitization (Fig. 1). 
Before skin grafting, lymphocytotoxins 
were never detectable and leukoagglu tinins 
were found in only one of 40 dogs. After 
sensitization, 22 of 40 animals (54 percent) 
developed leukoagglutinins in titers of 1:2 to 
1 :64 (mean, 1:8), and 28 of 34 tested (82 
percent) had lymphocytotoxins (Fig. 1). 
Depletion of antibodies by homografts. 
When the sensitized recipients were ex-
posed to 24 kidneys, 10 livers, and 7 spleens 
of their skin donors, there was a fall of all 
the measured antibodies (Fig. 1), with the 
lymphocytotoxins least reduced. None of 
the three organs appeared to be a superior 
antibody remover in comparison with the 
others. 
In 21 of the foregoing recipients, kidneys 
were placed after the first organs had been 
removed. The residualleukoagglutinins were 
almost totally eliminated, the two kinds of 
hemagglutinins were further reduced, and 
as with the first organ homotransplantation 
the lymphocytotoxins were only minimally 
reduced (Fig. 1). 
Absorption of the antibodies by the whole 
organ homografts was proved in 12 special 
experiments in which arteriovenous gradi-
ents were obtained across the transplants. 
Extraction was evident of isoagglutinins, 
heterohemagglutinins, and leukoagglutinins. 
TITER IA 
HEMAGGLUTININS AGAINST DONOR 
RED BLOOD CELLS 
Skin + I Ddroft~ "First 
Organ 
......... 
\ 
...... ~ 
..... _._.-
2 t 
Definitive 
Kidney 
2 
1'16 LEUKOAGGLUTININS AGAINST DONOR 
WHITE BLOOD CELLS 
TITER 
14 
12 
10 
WHITE CELL 8 
COUNT 
xl()"3 per mm' 6 
4 
2 
Skin + I ~ycirst 
Oroon 
TOTAL WHITE 
2 t I 
Definitive 
Kidney 
M~+t--~~O~~t--~~O 
Firs! Definitive 
Organ Kidney 
TIME IN HOURS 
2 
TITER 1'4 
"10 
LYMPHOCYTES 
KILLED 
100 
75 
50 
25 
HEMAGGLUTININS AGAINST SHEEP 
RED BLOOD CELLS 
Skin ~ I Ddroft~ First 
Organ 
2 t 
lI---1( Liver 
_._ Spleln 
_ Kidney 
~ Control 
Kidney 
2 
Definitive 
Kidney 
LYMPHOCYTOXINS AGAINST 
DONOR LYMPHOCYTES 
Skin t. I 
Grafts Fi rst 
Organ 
............... 
.............. 
2 t 2 
Definitive 
Kidney 
35 
PLATELET COUNT 
I , 
30 '. 
25 
PLATELET 20 
IK~ ... _-0 
\. \ 
, \ 
I . 
I .. « '10. 
I r 
, I 
I I 
I I 
I I 
" 
COUNT 
x10·4 per mrn3 15 
10 
I 
5 
l~~t--~~~t~~~ 2 2 
First Definitive 
Organ Kidney 
TIME IN HOURS 
Fig. 1. Changes in humoral antibodies, peripheral white cell counts, and platelet counts dur-
ing the period of multiple skin grafting and at the time of a first and second whole organ 
transplantation from the same donor. Codes for the different kinds of first organs (kidney, 
spleen, and liver) are identified in the upper right graph. All second organs were kidneys. 
See text for details. 
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However, the lymphocytotoxins had much 
less significant arteriovenous differences. 
Depletion of the heterohemagglutinins by 
the homografts was unexpected. Conse-
quently absorption of this antibody by canine 
red cells and canine renal cells was tested. 
Only the renal cells absorbed these ag-
glutinins. 
Hematologic changes. In all 40 sensitized 
recipients, the numbers of peripheral plate-
lets and white blood cells fell within a few 
minutes after whole organ transplantation 
and then tended to return toward but not 
to pre-existing levels (Fig. 1). Liver trans-
plants caused more severe and lasting de-
pressions than spleens and kidneys (Fig. 1). 
When kidneys were transplanted secondar-
ily after removal of a first organ, there were 
again declines in the platelet and white cell 
counts (Fig. 1). Comparable fluctuations in 
the hematocrit did not occur. 
In the 12 experiments in which homograft 
arteriovenous gradients were obtained, plate-
lets and white cells in the venous effluent fell 
66 and 57 percent, respectively, from the 
arterial values within one minute following 
revascularization (Table I). The extensive-
ness of the clearance was indicated by ar-
terial leukopenia and thrombocytopenia 
(Table Il, 20 to 40 minutes later. In three 
other experiments in which a kidney, spleen, 
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or liver was transplanted to nonsensitized 
dogs, venous platelets and white cells fell 
32 and 41 percent, respectively, from the 
arterial values. However, the sequestration 
was so transient that the platelets and white 
cells in the systemic arterial blood fell de-
tectably in only one of the three experi-
ments. 
Coagulation changes. In the 12 sensitized 
dogs in which arterial and venous samples 
were obtained across primary homografts 
(7 renal, 2 splenic, and 3 hepatic) there was 
always a major consumption of all the mea-
sured clotting factors within a few minutes, 
to the greatest degree with the livers (Table 
I). In addition, prolongation of the thrombin 
time (10 of 12 experiments), shortening of 
the euglobulin lysis time (6/6), and the 
appearance of fibrin split products (4/6) 
indicated fibrinolysis. The arteriovenous gra-
dients tended to be eliminated with time but 
when new kidneys were then transplanted, 
consumption was seen again in these second 
organs (Table I). The changes in the sys-
temic aortic blood reflected those measured 
across the homografts but occurred later, 
usually at about 30 minutes. In 9 of the 
12 animals the coagulation tests of systemic 
blood returned essentially to normal. How-
ever, the other 3 dogs continued to have ab-
normalities that were too great to be ex-
Table I. Maximum arterial changes in formed blood elements and in coagulation tests after the 
and after the subsequent transplantation of 7 kidney homografts. By also repetitively analysing the 
organs 
I Platelet count (per mm.S) 
Leucocyte 
cou:!t 
(per mm.9 ) 
I 
Fibrinogen I Factor* II 
(mg. %) (% normal) 
Average maximum change in venous effluent compared to arterial bloodt 
Liver -420,000 -8,577 -194 -47 
Spleen -190,000 -5,233 -110 -).') 
First kidney -116,000 -4,536 -71 -\05 
Second kidney -89,000 -5,325 -46 -9.5 
Maximum changes in arterial bloodt 
Liver -358,000 -9,011 -257 -61 
Spleen -105,000 -2,996 -83 -20.5 
First kidney -49,000 -1,735 -59 -12 
Second kidney -76,000 -4,348 -34 -8.5 
Factor* V I Factor* VIII 
(% normal) (% normal) 
-44 -70 
-8'1 -76 
-15 -19 
-9.0 -15 
-8<! -76 
-<!5.5 -31 
-18.7 -27.5 
-10.1 -7 
*Normal (100 percent) activity was defined as that present in canine plasma pooled from B healthy donors. The figures given are 
tThe maximum arteriovenous gradients almost invariabJy developed within 1 to 5 minutes and then became progressively smaller 
aortic blood did not evolve until 20 to 40 minutes after the most extreme gradients. 
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plained solely by consumption within the 
homograft and in fact these alterations per-
sisted and became worse even after the 
organs were removed. In 2 of the latter 3 
animals the titers of leukoagglutinins or 
lymphocytotoxins or both were unusually 
high. 
When 3 nonsensitized dogs were given a 
renal, splenic, or hepatic transplant, con-
sumption of clotting factors and fibrinolysis 
occurred within the grafts. However, the 
gradient changes were relatively minor and 
of short duration. Moreover, abnormalities 
in the aortic blood became detectable only 
in the liver experiment. 
Effect of repetitive grafting. There were 
8 experiments in which a renal homograft 
was placed after the removal of a condition-
ing spleen ( 5 examples) or liver (3 ex-
amples). All but one of these kidneys func-
tioned for longer than the other paired 
donor kidneys which were transplanted to 
sensitized but unmodified control recipients 
(Fig. 2). 
In 5 other experiments, the conditioning 
organ was the first donor kidney which was 
revascularized in the recipient for 51 to 240 
minutes and removed. The other kidney was 
then placed. Urine excretion occurred from 
the second kidney for a mean of 75.8 hours. 
In 4 of the 5 individual animals the duration 
Renal homografts zn sensitized dogs 81 
of function was longer than the average in 
the 8 control experiments of the preceding 
paragraph. 
The fate of kidney homografts either pri-
marily placed or transplanted as second or-
gans could not be significantly correlated to 
titers of any special kind of antibody mea-
sured at the time of revascularization. 
Immunofluorescent and histologic studies. 
Immmunofluorescent and histologic studies 
were made on ten conditioning organs (4 
kidneys, 3 spleens, and 3 livers) at the time 
of their removal. Minimal amounts of IgG 
and B1C were present in all organs in a 
diffuse interstitial distribution without any 
significant anatomic concentrations. Fibrin 
was present in focal deposits randomly dis-
tributed in the spleens. Lesser amounts were 
seen concentrated about the hepatic arteries 
in the liver and in the peri tubular capillary 
areas of the kidneys. Light fibrin deposits 
were seen along glomerular capillary walls 
in three of four conditioning kidneys. Routine 
histologic examination revealed moderate 
numbers of polymorphonuclear (PMN) leu-
kocytes in glomeruli of the kidney examined 
earliest following transplantation. A few 
PMN leukocytes were seen in the glomeruli 
of the remaining kidneys and in the paren-
chyma of the livers and spleens. There was 
little evidence of thrombosis. 
transplantation to sensitized recipients of 12 primary homografts (3 livers, 2 spleens, and 7 kidneys) 
venous effluent, the maximum arteriovenous (A- V) gradients were established across the various 
Factor* IX Thrombin time Prothrombin time Partial thromboplastin Euglobulin lysis Fibrin split 
(% normal) (sec.) (sec.) time (sec.) time (min.) products 
-48 +40 +5.4 +9.3 
-31 +3.8 +4.1 +3.0 
-44 +3.3 +0.3 +1.7 
-19 +4.5 +1.7 +2.2 
-38 +7.5 +3.2 +14.2 -49 ++ 
-55 +1.4 +2.2 +3.5 -50 + 
-29.2 +2.3 +0.3 +2.8 -22 + 
-16 +1.8 +1.4 +4.3 -16 + 
the mean changes in percentage activity. 
with the passage of time. However, there were continuing changes in the systemic blood so that the maximum alterations in the 
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Fig. 2. Functional times of kidney homografts after transplantation to sensitized unmodified 
recipients (control) compared to the functional intervals when kidneys were inserted into 
comparably sensitized recipients but as second organs following spleens, livers or kidneys. A 
description of the control and test animals is in the text. 
Serial biopsies on one dog with dissem-
inated intravascular coagulation indicated a 
changing pattern of fibrin deposition with 
time. Seventy minutes after anastomosis of 
the second kidney fibrin was deposited largely 
in glomeruli and about peri tubular capillar-
ies. At 2 hours the glomerular deposits had 
largely disappeared. At 35 hours, one day 
after cessation of function, fibrin was found 
primarily in small arteries and about peri-
tubular capillaries of the transplant. At this 
time, the dog's own kidney contained only 
small amounts of fibrin about peritubular 
capillaries. 
DISCUSSION 
The relationship of two specific factors to 
accelerated or hyperacute rejection were 
examined in this study. The first was the 
pre-existence of a family of circulating anti-
red cell and anti-white cell antibodies 
which appeared coincident with sensitization 
to donor skin and which could be absorbed 
by the cells of the donor. The second factor 
was the coagulation process coincident with 
the rapid destruction of the grafts. 
The fact that humoral antibodies seemed 
to be an integral part of the sensitized state 
was not unexpected. Since the publications of 
Gorer and O'Gorman7 and Stetson19 the con-
cept has been frequently advanced that ho-
mograft rejection is due not only to cell medi-
ated immunity but to an immunoglobulin 
response as well. In human recipients of re-
nal transplants, antigraft antibodies have 
been found in an incidence that varied with 
the sensitivity of the detection method used. 
Moreover, recent publications have under-
scored the bad prognostic implications of 
antibodies particularly if these antedated op-
eration.ll, 18, 22, 25 
It remains to be settled if certain tests 
such as the mixed agglutination method of 
Klassen and Milgromll detect unusually 
harmful antibodies in an especially discrim-
inating way. The mixed agglutination test 
was not employed in this present study. 
However, the different antibodies analyzed 
tended to rise or fall in parallel with sensi-
tization or depletion procedures, although 
the lymphocytotoxins proved to be the most 
resistant to absorption. The heterogeneity 
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of the response to the skin grafts was con-
sistent with the fact that well studied histo-
compatibility loci determine not only the 
nature of cell mediated reactions but also 
a wide range of humoral antibody responses, 
including those with anti-red cell and anti-
white cell activity. 7 
The controversial aspect of the presensi-
tized state has not been whether humoral 
antibodies playa role in rejection but rather 
how their injurious effects are mediated. 
Clinical observations from our own institu-
tion1S were interpreted as indicating that an 
immediate antigen antibody reaction follow-
ing revascularization of renal homografts 
caused alterations in coagulation, leading to 
deposition of fibrin in the homograft vascu-
lature and an ultimate pathologic appear-
ance which resembled the Shwartzman reac-
tion. This view of the pathogenetic role of 
clotting was not confirmed by Colman and 
MerrilP but indirectly supported by the ob-
servations of MacDonald and associates12 
who showed that hyperacute renal rejection 
could be regularly prevented in sensitized 
dogs by prophylactic heparin therapy. 
The present study provided strong evi-
dence that acute coagulation changes are in 
fact precipitated by an immeditae im-
munologic reaction when homografts are 
transplanted to sensitized recipients. Invari-
ably, there was consumption within the trans-
plants of platelets and all measured clotting 
factors. Furthermore, in a fourth of the ex-
periments there developed a systemic clotting 
disorder indistinguishable from that of dis-
seminated intravascular coagulation (DIC). 
These observations were consistent with the 
immunofluorescent detection of fibrin de-
posits in all conditioning grafts. The single 
definitive graft studied by serial biopsies 
showed early deposition and rapid removal 
of fibrin suggesting active fibrinolysis ac-
companying this coagulation process. With 
either the localized or general coagulopathy 
the transplanted organs were at specific risk 
since the native kidneys or other host organs 
were not perceptibly harmed as "innocent 
bystanders" at the same time as the homo-
graft was undergoing variable damage, and 
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as fibrin became deposited in its vasculature. 
The means of inducing this local and/or 
generalized coagulopathy have not been 
identified but our experimental observations 
suggest a likely mechanism. Since the induced 
antibodies appear to react with antigens in 
the transplants, clotting could be induced 
directly by the antibody-antigen reaction. 1, 17 
In addition, antibody-antigen reactions at-
tract PMN leukocytes via C' activation24 
and these white cells appear capable of in-
ducing clotting9 and are essential in the 
causation of the thrombosis seen in the local20 
and generalized9 ,10 Shwartzman reactions. 
Our failure to find large numbers of PMN 
leukocytes in these grafts may have been be-
cause our observations were too late, i.e., 
after cessation of leukocyte sequestration in 
the graft. Heavy PMN accumulations and 
thrombosis have been seen in man where 
preformed antibodies induced immediate 
hyperacute rejections of renal transplants. IS, 25 
One objective of the present study was to 
evaluate means of mitigating hyperacute or 
accelerated rejection. This was achieved by 
transplanting successive organs from the 
same donor. The reason for protection can-
not be precisely defined from our observa-
tions although the absorption of humoral 
antibodies by the first or conditioning organ 
is the most obvious explanation. However, it 
is conceivable that the coincident depletion 
of the clotting factors could have been re-
sponsible in part for the extended survival 
of the second organ. 
SUMMARY 
Dogs were sensitized with repeated skin 
homotransplantation and then given a spleen, 
kidney, or liver from their skin donor. Coin-
cident with sensitization, there developed a 
family of anti-donor antibodies which ap-
parently participated in the accelerated or 
hyperacute rejection of the whole organs. 
An important component of the destructive 
process was a coagulopathy which always oc-
curred within the grafts and which some-
times led to systemic alterations resembling 
a disseminated intravascular coagulation. 
Kidneys were usually temporarily protected 
84 Simpson et al. 
from hyperacute rejection by the prior trans-
plantation of another organ (kidney, spleen, 
or liver) from the same donor. 
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DISCUSSION 
Dr. John S. Najarian (Minneapolis, Minn.). 
The presensitized host is an extremely important 
problem to us, because we see many patients who 
have had previous transplants, and are looking at 
the possibility of sensitized hosts. I would suggest 
injecting cells into these patients as a method of 
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sensitization. Sometimes we found that skin grafts 
did not produce hypersensitization often enough, 
because the skin graft develops no good vascular 
supply when it becomes sensitized, and subse-
quent poorly vascularized grafts after the second 
one cause poor sensitization. Perhaps cell injec-
tion would help heighten the level of antibody, 
if that is needed-and I am not sure that it is. 
Dr. Starzl, we have worked with a hypersensi-
tized model, and also with the xenograft. There 
are many similarities in these two. Both have pre-
formed antibody. That is, there is an antigen-
antibody reaction that occurs in the kidney. The 
xenograft differs from the hypersensitized model 
in that the platelets are used up, and all the 
other coagulation parameters as well across the 
A/V difference of the organ. 
We found no alteration in prothrombin time. 
The extrinsic factors seem to play no part in 
this. It seems to be one of the intrinsic factors. 
We do not find any DIC in the xenograft 
. model. In liver transplants, when the liver is our 
immunoabsorbent, we do see DIC systemically, 
but with most other organs we do not. This is 
probably an overwhelming coagulation consump-
tion defect in this case. 
I would like to help answer one question 
raised: What is one doing when he is putting in 
the immunoabsorptive organ? Is it just absorbing 
antibody, or is it a factor that is altering coagula-
tion? . 
We have used a Malayan pit viper venom, 
which is an excellent way of defibrinating blood, 
and of eliminating most of the coagulation prob-
lem. Then, with no coagulation whatsoever, the 
xenograft still rejects in the same time. Tem-
porally it is just as in the hypersensitized model. 
This indicates that coagulation is not the 
main thing. The xenograft is not thrombosed, but 
congested and hemorrhagic; rejection occurs at 
the same rate. 
We think, therefore, that the antibody is being 
absorbed, and that if the antibody is removed by 
other means, such as the electrophorectic filter, 
one can delay rejection. So we think the anti-
body is important. 
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One difference is that in the xenograft model 
the leukocytes do not drop in the AIV difference, 
so that this reaction can occur with only anti-
bodies and antigen. Of course, this is a standard 
immunological model, which activates comple-
ment, and complement activates coagulation fac-
tors. We wonder if this is what is going on. 
Dr. Starzl (closing). Dr. Najarian, I am in-
clined to agree with you that the skin sensitization 
method we used was wasteful, and that with the 
white graft state one no longer really gets a boost 
every time the skin is put on. Drs. McDonald 
and Murray, in Boston, buried their skin, and, 
in a way, lessened this objection. Perhaps the 
injection of intravenous cells is also a good idea. 
We also believe that the hyperacute rejection 
of homografts is similar to xenograft rejection 
across diverse species barriers such as the pig-dog 
combination with which Dr. Najarian has worked. 
Also, it is clear that coagulation plays a major 
role in xenograft rejection. Dr. Rosenthal and his 
associates from Wayne State University have 
shown this very clearly (Transplantation 8: 152, 
1969) by demonstrating consumption of several 
clotting factors as well as platelets. In our labora-
tory Drs. Geoffrey Giles and Hans J. Boehmig 
have found an almost immediate consumption of 
platelets as well as factors I, II, V, VIII, and 
IX. In these xenograft experiments, Giles and 
Boehmig have not yet observed a DIC such as 
that described in the main text. It may be that 
xenografts from pigs to dogs or dogs to pigs are 
destroyed so rapidly and thereby excluded from 
the circulation that there is no time for a systemic 
coagulation disorder to develop. 
I would like to add a final comment about the 
clinical relevance of this study. We have seen 
DIC exactly as Dr. Blaisdell defined it in two 
renal transplant recipients. In one we placed two 
consecutive organs, the first to deplete antibodies-
we hoped-but when the second one was placed, 
the patient had an immediate bleeding diathesis. 
The second patient died from a systemic coagula-
tion disorder with a consequent bleeding diathesis. 
